Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?

Details

Ressource 1Download: 26374690AM.pdf (307.91 [Ko])
State: Public
Version: Author's accepted manuscript
Serval ID
serval:BIB_B81E79A4FF80
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
UNIL/CHUV
Title
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?
Journal
Neuro-oncology
Author(s)
Hegi M.E., Stupp R.
ISSN
1523-5866 (Electronic)
ISSN-L
1522-8517
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
17
Number
11
Pages
1425-1427
Language
english
Notes
Publication types: Editorial
Publication Status: ppublish
Keywords
Antineoplastic Agents/therapeutic use, Brain Neoplasms/drug therapy, Brain Neoplasms/genetics, DNA Methylation/genetics, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Dacarbazine/analogs & derivatives, Dacarbazine/therapeutic use, Glioblastoma/drug therapy, Glioblastoma/genetics, Humans, Promoter Regions, Genetic/genetics, Tumor Suppressor Proteins/genetics
URN
urn:nbn:ch:serval-BIB_B81E79A4FF807
OAI-PMH
oai:serval.unil.ch:BIB_B81E79A4FF80
DOI
10.1093/neuonc/nov198
Pubmed
26374690
Web of science
000364783900001
Open Access
Yes
Create date
22/12/2015 17:42
Last modification date
20/08/2019 15:26
Usage data